Suchergebnisse - "Bergman, Arthur J"

PubPharm (52)

1

Investigation of pharmacokinetic drug interaction between clesacostat and DGAT2 inhibitor ervogastat in healthy adult participants

enthalten in: Clinical and translational science | 2024

von Sawant-Basak, A. | Bergman, A. | Mancuso, J. | +5

2

Investigation of pharmacokinetic drug interaction between clesacostat and DGAT2 inhibitor ervogastat in healthy adult participants

enthalten in: Clinical and Translational Science | 2024

von Sawant‐Basak, A. | Bergman, A. | Mancuso, J. | +5

3

Metabolism and Excretion of Nirmatrelvir in Humans Using Quantitative Fluorine Nuclear Magnetic Resonance Spectroscopy : A Novel Approach for Accelerating Drug Development

enthalten in: Clinical pharmacology and therapeutics | 2022

von Singh, R. | Walker, G. | Kadar, E. | +9

4

Metabolism and Excretion of Nirmatrelvir in Humans Using Quantitative Fluorine Nuclear Magnetic Resonance Spectroscopy : A Novel Approach for Accelerating Drug Development

enthalten in: Clinical Pharmacology & Therapeutics | 2022

von Singh, R. | Walker, G. | Kadar, E. | +9

5

Inhibition of ketohexokinase in adults with NAFLD reduces liver fat and inflammatory markers : A randomized phase 2 trial

enthalten in: Med (New York, N.Y.) | 2021

von Kazierad, D. | Chidsey, K. | Somayaji, V. | +3

6

Mini-Review : Comprehensive Drug Disposition Knowledge Generated in the Modern Human Radiolabeled ADME Study

enthalten in: CPT: pharmacometrics & systems pharmacology | 2020

von Spracklin, D. | Chen, D. | Bergman, A. | +2

7

Efficacy and safety of the glucagon receptor antagonist PF-06291874 : A 12-week, randomized, dose-response study in patients with type 2 diabetes mellitus on background metformin therapy

enthalten in: Diabetes, obesity & metabolism | 2018

von Kazierad, D. | Chidsey, K. | Somayaji, V. | +2

8

Efficacy and safety of the glucagon receptor antagonist PF‐06291874 : A 12‐week, randomized, dose‐response study in patients with type 2 diabetes mellitus on background metformin therapy

enthalten in: Diabetes, Obesity and Metabolism | 2018

von Kazierad, D. | Chidsey, K. | Somayaji, V. | +2

9

Effect of different durations and formulations of diltiazem on the single-dose pharmacokinetics of midazolam : how long do we go?

enthalten in: Journal of clinical pharmacology | 2011

von Friedman, E. | Fraser, I. | Wang, Y. | +6

10

Effect of Different Durations and Formulations of Diltiazem on the Single-Dose Pharmacokinetics of Midazolam: How Long Do We Go?

enthalten in: The journal of clinical pharmacology | 2011

von Friedman, E. | Fraser, I. | Wang, Y. | +6

1
2
3
4
5
6
Nächster »
[6]